Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Protara Therapeutics, Inc. (TARA) had Return on Investments of -14.96% for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-10.22M |
|
-- |
|
-- |
|
$11.04M |
|
$-11.04M |
|
$0.82M |
|
$-10.22M |
|
$-10.22M |
|
$-10.22M |
|
$-10.22M |
|
$-10.22M |
|
$-10.22M |
|
$-11.04M |
|
$-10.03M |
|
11.33M |
|
11.33M |
|
$-0.90 |
|
$-0.90 |
|
| Balance Sheet Financials | |
$68.70M |
|
$1.30M |
|
$10.25M |
|
$78.95M |
|
$6.15M |
|
-- |
|
$4.48M |
|
$10.63M |
|
$68.32M |
|
$68.32M |
|
$68.32M |
|
11.37M |
|
| Cash Flow Statement Financials | |
$-37.56M |
|
$53.11M |
|
$-0.09M |
|
$24.87M |
|
$40.33M |
|
$15.46M |
|
$6.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-37.60M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.96% |
|
-14.96% |
|
-12.95% |
|
|
Return on Investments |
-14.96% |
$6.01 |
|
$-3.32 |
|
$-3.31 |
|